1. Home
  2. MREO vs PML Comparison

MREO vs PML Comparison

Compare MREO & PML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • PML
  • Stock Information
  • Founded
  • MREO 2015
  • PML 2002
  • Country
  • MREO United Kingdom
  • PML United States
  • Employees
  • MREO N/A
  • PML N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • PML Investment Managers
  • Sector
  • MREO Health Care
  • PML Finance
  • Exchange
  • MREO Nasdaq
  • PML Nasdaq
  • Market Cap
  • MREO 424.5M
  • PML 508.5M
  • IPO Year
  • MREO N/A
  • PML N/A
  • Fundamental
  • Price
  • MREO $2.15
  • PML $7.49
  • Analyst Decision
  • MREO Strong Buy
  • PML
  • Analyst Count
  • MREO 7
  • PML 0
  • Target Price
  • MREO $7.71
  • PML N/A
  • AVG Volume (30 Days)
  • MREO 943.2K
  • PML 188.0K
  • Earning Date
  • MREO 05-13-2025
  • PML 01-01-0001
  • Dividend Yield
  • MREO N/A
  • PML 5.65%
  • EPS Growth
  • MREO N/A
  • PML N/A
  • EPS
  • MREO N/A
  • PML N/A
  • Revenue
  • MREO N/A
  • PML N/A
  • Revenue This Year
  • MREO N/A
  • PML N/A
  • Revenue Next Year
  • MREO $54.91
  • PML N/A
  • P/E Ratio
  • MREO N/A
  • PML N/A
  • Revenue Growth
  • MREO N/A
  • PML N/A
  • 52 Week Low
  • MREO $1.58
  • PML $6.92
  • 52 Week High
  • MREO $5.02
  • PML $9.46
  • Technical
  • Relative Strength Index (RSI)
  • MREO 40.94
  • PML 41.21
  • Support Level
  • MREO $2.12
  • PML $7.40
  • Resistance Level
  • MREO $2.27
  • PML $7.51
  • Average True Range (ATR)
  • MREO 0.13
  • PML 0.10
  • MACD
  • MREO -0.02
  • PML -0.01
  • Stochastic Oscillator
  • MREO 9.09
  • PML 22.50

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About PML Pimco Municipal Income Fund II of Beneficial Interest

PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.

Share on Social Networks: